Clinical Study
Association of the HLA-DQA1 and HLA-DQB1 Alleles in Type 2 Diabetes Mellitus and Diabetic Nephropathy in the Han Ethnicity of China
Table 1
Clinical and biochemical parameters of the controls and diabetic subjects.
| | T2DM patients | | | Without DN group | DN group |
Controls |
| | 100 | 210 | 100 | Age | 57.8 ± 9.5 | 58.1 ± 8.7 | 57.5 ± 4.7 | Gender (male/female) | 47/53 | 105/105 | 50/50 | Age at diagnosis of DM (years) | 53.3 ± 10.5 | 51.7 ± 8.3# | — | Diabetes duration (years) | 13.2 ± 2.7 |
16.1 ± 4.5† | — | BMI (kg/m2) | 25.5 ± 3.6* | 25.8 ± 4.0* | 23.1 ± 3.8 | Hypertension (%) | 47 (47%)* | 152 (72.4%)†* | 23 (23%) | SBP (mmHg) | 136.2 ± 16.5* | 144.1 ± 17.6†* | 130.4 ± 15.7 | DBP (mmHg) | 80.7 ± 9.5* | 83.2 ± 9.6†* | 76.1 ± 8.9 | FPG (mmol/L) | 9.3 ± 5.8* | 9.5 ± 6.4* | 5.1 ± 3.7 | HbA1c (%) | 9.2 ± 4.3* | 9.3 ± 5.7* | 5.2 ± 2.8 | Triglyceride level (mmol/L) | 1.4 ± 0.7* | 1.8 ± 0.9†* | 1.1 ± 0.6 | Total cholesterol level (mmol/L) | 4.8 ± 1.2 | 4.9 ± 1.4 | 4.7 ± 1.5 |
|
|
Data are expressed as means ± SD and (%); versus controls; #P < 0.05 versus without DN group; versus without DN group.
|